Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgrounds.
Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgrounds.
复制标题
Interleukin-37 可改善老年背景下的 T 细胞介导的免疫和嵌合抗原受体 T 细胞治疗。
DOI:
10.1111/acel.13309
复制
发表时间:
2021-03
期刊:
影响因子:
7.8
通讯作者:
Henry CJ
中科院分区:
文献类型:
--
作者:
Hamilton JAG;Lee MY;Hunter R;Ank RS;Story JY;Talekar G;Sisroe T;Ballak DB;Fedanov A;Porter CC;Eisenmesser EZ;Dinarello CA;Raikar SS;DeGregori J;Henry CJ
Aging‐associated declines in innate and adaptive immune responses are well documented and pose a risk for the growing aging population, which is predicted to comprise greater than 40 percent of the world's population by 2050. Efforts have been made to improve immunity in aged populations; however, safe and effective protocols to accomplish this goal have not been universally established. Aging‐associated chronic inflammation is postulated to compromise immunity in aged mice and humans. Interleukin‐37 (IL‐37) is a potent anti‐inflammatory cytokine, and we present data demonstrating that IL‐37 gene expression levels in human monocytes significantly decline with age. Furthermore, we demonstrate that transgenic expression of interleukin‐37 (IL‐37) in aged mice reduces or prevents aging‐associated chronic inflammation, splenomegaly, and accumulation of myeloid cells (macrophages and dendritic cells) in the bone marrow and spleen. Additionally, we show that IL‐37 expression decreases the surface expression of programmed cell death protein 1 (PD‐1) and augments cytokine production from aged T‐cells. Improved T‐cell function coincided with a youthful restoration of Pdcd1, Lat, and Stat4 gene expression levels in CD4+ T‐cells and Lat in CD8+ T‐cells when aged mice were treated with recombinant IL‐37 (rIL‐37) but not control immunoglobin (Control Ig). Importantly, IL‐37‐mediated rejuvenation of aged endogenous T‐cells was also observed in aged chimeric antigen receptor (CAR) T‐cells, where improved function significantly extended the survival of mice transplanted with leukemia cells. Collectively, these data demonstrate the potency of IL‐37 in boosting the function of aged T‐cells and highlight its therapeutic potential to overcome aging‐associated immunosenescence. Aging is associated with chronic inflammation (inflammaging) and immunosenescence, which are thought to promote cancer development. Here, we demonstrate that treating aged mice with the anti‐inflammatory cytokine interleukin‐37 (IL‐37) abrogates inflammaging, suppresses the expression of immunoinhibitory proteins on aged T‐cells, and rejuvenates effector responses. Importantly, we found that recombinant IL‐37 treatment augments the efficacy of aged CAR T‐cells in murine models of leukemia.
登录
查看更多内容
DOI:
10.1084/jem.20131219
发表时间:
2013-10-21
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Bouchlaka MN;Sckisel GD;Chen M;Mirsoian A;Zamora AE;Maverakis E;Wilkins DE;Alderson KL;Hsiao HH;Weiss JM;Monjazeb AM;Hesdorffer C;Ferrucci L;Longo DL;Blazar BR;Wiltrout RH;Redelman D;Taub DD;Murphy WJ
通讯作者:
Murphy WJ
DOI:
10.1084/jem.185.9.1573
发表时间:
1997-05-05
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Cope AP;Liblau RS;Yang XD;Congia M;Laudanna C;Schreiber RD;Probert L;Kollias G;McDevitt HO
通讯作者:
McDevitt HO
影响因子:
20.3
作者:
Boulos, Nidal;Mulder, Heather L.;Williams, Richard T.
通讯作者:
Williams, Richard T.
DOI:
10.4049/jimmunol.1402550
发表时间:
2015-05-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Bally AP;Lu P;Tang Y;Austin JW;Scharer CD;Ahmed R;Boss JM
通讯作者:
Boss JM
影响因子:
--
作者:
Bayraktar, Soley;Batoo, Sameer;Gluck, Stefan
通讯作者:
Gluck, Stefan